机构:[1]Department of Anesthesiology, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, Guangdong Province[2]Department of Otorhinolaryngology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province,[3]Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University. No 1, Nanchang, Jiangxi, People’s Republic of China
Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in Asia particularly southern China. Comparisons of outcomes of conformal radiotherapy (CRT) and intensity-modulated radiotherapy (IMRT) have been still debated. This meta-analysis was carried out to compare oncologic outcomes of CRT and IMRT in the treatment of NPC.
A literature search was performed through PubMed, Embase, and the Cochrane library databases from their inceptions to November 10, 2018. Two authors assessed the included studies and extracted data independently. Relative studies that compared oncologic outcomes between CRT and IMRT for NPC were included.
A total of 13 eligible studies were included, which contained 1 RCT, 1 prospective study, and 11 retrospective studies. Our meta-analysis showed that IMRT has increased overall survival (OR = 0.51, 95% CI = 0.41-0.65, P < .00001), locoregional control rate (OR = 0.59, 95% CI = 0.52-0.67, P < .00001), disease-free survival (OR = 0.77, 95% CI = 0.65-0.91, P = .002), and metastasis-free survival (OR = 0.71, 95% CI = 0.54-0.94, P = .01) in comparison with CRT.
The results of this meta-analysis indicate IMRT should be a better option for the treatment of NPC because patients who underwent IMRT may benefit from increased overall survival, locoregional control rate, disease-free survival, and metastasis-free survival compared with CRT.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|4 区医学
小类|3 区医学:内科
最新[2025]版:
大类|4 区医学
小类|4 区医学:内科
第一作者:
第一作者机构:[1]Department of Anesthesiology, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, Guangdong Province
共同第一作者:
通讯作者:
通讯机构:[3]Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University. No 1, Nanchang, Jiangxi, People’s Republic of China[*1]Department of Otolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University. No 1, Minde Road, Nanchang, Jiangxi 330006, People’s Republic of China
推荐引用方式(GB/T 7714):
Luo Meng-Si,Huang Guan-Jiang,Liu Hong-Bing.Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis.[J].Medicine.2019,98(24):e15951.doi:10.1097/MD.0000000000015951.
APA:
Luo Meng-Si,Huang Guan-Jiang&Liu Hong-Bing.(2019).Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis..Medicine,98,(24)
MLA:
Luo Meng-Si,et al."Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis.".Medicine 98..24(2019):e15951